Rapid discovery of potential ADR compounds from injection of total saponins from Panax notoginseng using data-independent acquisition untargeted metabolomics

• Published in: Analytical and bioanalytical chemistry 2022, Vol.414 (2), p.1081-1093
• Main Authors: Wang, Chenxi, Pang, Xu, Zhu, Tongtong, Ma, Shuhua, Liang, Yunfei, Zhang, Yi, Lan, Xing, Wang, Tao, Han, Lifeng
• Format: Article
• Language: English
• Subjects: Adverse and side effects; Analysis; Analytical Chemistry; Biochemistry; Cerebrovascular system; Characterization and Evaluation of Materials; Chemistry; Chemistry and Materials Science; Chinese medicine; Chromatography; Chromatography, High Pressure Liquid - methods; Cytotoxicity; Degranulation; Drug Discovery; Drugs; Endocrine system; Food Science; Ginsenosides; Herbal medicine; High performance liquid chromatography; Humans; Identification and classification; Injection; Laboratories; Laboratory Medicine; Liquid chromatography; Mass spectrometry; Metabolites; Metabolomics; Metabolomics - methods; Methods; Monitoring/Environmental Analysis; Notoginseng; Open source software; Ophthalmology; Panax notoginseng; Panax notoginseng - chemistry; Properties; Quadrupoles; Quality standards; Research Paper; Saponins; Saponins - administration & dosage; Saponins - adverse effects; Saponins - chemistry; Scientific imaging; Side effects; Toxicity; Traditional Chinese medicine
• ISSN: 1618-2642; 1618-2650
• DOI: 10.1007/s00216-021-03734-5

Injection of total saponins from Panax notoginseng (ISPN) is a modern preparation derived from traditional Chinese medicine (TCM) and is widely applied in the treatment of cardiovascular, cerebrovascular, ophthalmology, and endocrine system diseases. With the increase in the clinical application of ISPN, its adverse drug reactions (ADRs) and related safety issues have attracted much attention. In the present study, a data-independent acquisition (DIA) strategy was proposed to comprehensively characterize the saponins contained in ISPN based on the ultra-high-performance liquid chromatography/quadrupole-Orbitrap MS (UHPLC/Q-Orbitrap MS) platform. As many as 276 saponins were detected, and 250 compounds were identified or tentatively identified based on the retention times and MS/MS data. Furthermore, a metabolomic strategy was utilized to discover the discriminative saponins between normal and ADR batches. The results showed that six saponins, including ginsenoside Rh4, ginsenoside Rk3, ginsenoside Rg5, ginsenoside Rk1, ginsenoside Rg6, and 20( S )-ginsenoside Rh2, were significantly different between the two groups. According to cytotoxicity analysis and degranulation detection of RBL-2H3 cells, ginsenoside Rg5, ginsenoside Rk1, and 20( S )-ginsenoside Rh2 were considered the potential compounds responsible for clinical ADRs, ultimately. In addition, the quantitative analysis showed that the content of these three compounds in ISPN samples with ADRs was generally higher than that in samples without ADRs. This study demonstrated that it is advisable to screen out potential markers related to ADRs for developing the quality standard of ISPN by the integration of untargeted metabolomic analysis and cell biology study, and thus reduce its ADRs in the clinic. Graphical abstract